• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lifestyle and Lipoprotein(a) Levels: Does a Specific Counseling Make Sense?生活方式与脂蛋白(a)水平:特定的咨询有意义吗?
J Clin Med. 2024 Jan 28;13(3):751. doi: 10.3390/jcm13030751.
2
Dietary natural products as emerging lipoprotein(a)-lowering agents.膳食天然产物作为新兴的脂蛋白(a)降低剂。
J Cell Physiol. 2019 Aug;234(8):12581-12594. doi: 10.1002/jcp.28134. Epub 2019 Jan 13.
3
Lipoprotein(a): Current Evidence for a Physiologic Role and the Effects of Nutraceutical Strategies.脂蛋白(a):生理作用的现有证据和营养策略的影响。
Clin Ther. 2019 Sep;41(9):1780-1797. doi: 10.1016/j.clinthera.2019.06.002. Epub 2019 Jul 13.
4
5
Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives.脂蛋白(a)作为心血管疾病的危险因素:病理生理学和治疗观点。
Int J Environ Res Public Health. 2023 Sep 6;20(18):6721. doi: 10.3390/ijerph20186721.
6
Efficacy of Traditional Anti-lipidemic Drugs in Lowering Lipoprotein(a) Levels: A Systematic Review.传统抗血脂药物降低脂蛋白(a)水平的疗效:一项系统评价
Cureus. 2024 Sep 20;16(9):e69824. doi: 10.7759/cureus.69824. eCollection 2024 Sep.
7
Dietary alpha-cyclodextrin lowers low-density lipoprotein cholesterol and alters plasma fatty acid profile in low-density lipoprotein receptor knockout mice on a high-fat diet.膳食α-环糊精可降低高脂饮食的低密度脂蛋白受体敲除小鼠的低密度脂蛋白胆固醇水平,并改变其血浆脂肪酸谱。
Metabolism. 2008 Aug;57(8):1046-51. doi: 10.1016/j.metabol.2008.02.020.
8
Effects of exercise on lipoprotein(a).运动对脂蛋白(a)的影响。
Sports Med. 1999 Jul;28(1):11-24. doi: 10.2165/00007256-199928010-00002.
9
Lipoprotein(a) and its Significance in Cardiovascular Disease: A Review.脂蛋白(a)及其在心血管疾病中的意义:综述。
JAMA Cardiol. 2022 Jul 1;7(7):760-769. doi: 10.1001/jamacardio.2022.0987.
10
Flaxseed Supplementation Reduces Plasma Lipoprotein(a) Levels: A Meta-Analysis.亚麻籽补充剂可降低血浆脂蛋白(a)水平:一项荟萃分析。
Altern Ther Health Med. 2021 May;27(3):50-53.

引用本文的文献

1
A 360° perspective on cardiovascular prevention: the International Lipid Expert Panel SiMple tIps for the heaLthy hEart (ILEP-SMILE).心血管预防的360°视角:国际脂质专家小组的健康心脏简易小贴士(ILEP-SMILE)
Arch Med Sci. 2025 May 29;21(3):711-718. doi: 10.5114/aoms/205732. eCollection 2025.
2
Lipoprotein(a) associates with high-resolution MRI-assessed intracranial plaque vulnerability and long-term stroke recurrence.脂蛋白(a)与高分辨率MRI评估的颅内斑块易损性及长期卒中复发相关。
Eur Radiol. 2025 Jun 16. doi: 10.1007/s00330-025-11748-1.
3
Lp(a)-Lowering Agents in Development: A New Era in Tackling the Burden of Cardiovascular Risk?正在研发的Lp(a)降低药物:应对心血管疾病风险负担的新时代?
Pharmaceuticals (Basel). 2025 May 19;18(5):753. doi: 10.3390/ph18050753.
4
Cholesterol-Lowering Bioactive Foods and Nutraceuticals in Pediatrics: Clinical Evidence of Efficacy and Safety.儿科降脂生物活性食品和营养保健品:疗效和安全性的临床证据。
Nutrients. 2024 May 18;16(10):1526. doi: 10.3390/nu16101526.
5
Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?脂蛋白(a)与动脉粥样硬化性心血管疾病:我们处于何种立场?
Int J Mol Sci. 2024 Mar 21;25(6):3537. doi: 10.3390/ijms25063537.

本文引用的文献

1
Efficacy and safety of inclisiran a newly approved FDA drug: a systematic review and pooled analysis of available clinical studies.新批准的美国食品药品监督管理局(FDA)药物英克西兰的疗效与安全性:现有临床研究的系统评价与汇总分析
Am Heart J Plus. 2022 Apr 2;13:100127. doi: 10.1016/j.ahjo.2022.100127. eCollection 2022 Jan.
2
Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting.在真实世界环境中估计可能适合脂蛋白(a)降低疗法的患者的患病率和特征。
Biomedicines. 2023 Dec 12;11(12):3289. doi: 10.3390/biomedicines11123289.
3
Sex X Time Interactions in Lp(a) and LDL-C Response to Evolocumab.脂蛋白(a)和低密度脂蛋白胆固醇对依洛尤单抗反应中的性别X时间交互作用
Biomedicines. 2023 Dec 11;11(12):3271. doi: 10.3390/biomedicines11123271.
4
L-shaped association between dietary coenzyme Q10 intake and high-sensitivity C-reactive protein in Chinese adults: a national cross-sectional study.中国人的辅酶 Q10 饮食摄入量与高敏 C 反应蛋白之间呈 L 型关联:一项全国性横断面研究。
Food Funct. 2023 Oct 30;14(21):9815-9824. doi: 10.1039/d3fo00978e.
5
Low carbohydrate/ketogenic diet in the optimization of lipoprotein(a) levels: do we have sufficient evidence for any recommendation?低碳水化合物/生酮饮食对脂蛋白(a)水平的优化作用:我们是否有足够证据做出任何推荐?
Eur Heart J. 2023 Dec 14;44(47):4904-4906. doi: 10.1093/eurheartj/ehad635.
6
Assessment of Apolipoprotein(a) Isoform Size Using Phenotypic and Genotypic Methods.使用表型和基因型方法评估载脂蛋白(a)异构体大小。
Int J Mol Sci. 2023 Sep 9;24(18):13886. doi: 10.3390/ijms241813886.
7
Is there a benefit of aspirin therapy for primary prevention to reduce the risk of atherosclerotic cardiovascular disease in patients with elevated Lipoprotein (a)-A review of the evidence.对于脂蛋白升高的患者,阿司匹林治疗在一级预防中降低动脉粥样硬化性心血管疾病风险是否有益——证据综述
Am J Prev Cardiol. 2023 Sep 1;15:100579. doi: 10.1016/j.ajpc.2023.100579. eCollection 2023 Sep.
8
Healthy lifestyle, lipoprotein (a) levels and the risk of coronary artery disease.健康生活方式、脂蛋白(a)水平与冠状动脉疾病风险
Eur J Clin Invest. 2024 Jan;54(1):e14093. doi: 10.1111/eci.14093. Epub 2023 Sep 15.
9
Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a).用于高脂蛋白血症(a)管理的新型药理学疗法。
Int J Mol Sci. 2023 Sep 3;24(17):13622. doi: 10.3390/ijms241713622.
10
Association of free-living diet composition with plasma lipoprotein(a) levels in healthy adults.健康成年人自由生活饮食组成与血浆脂蛋白(a)水平的关系。
Lipids Health Dis. 2023 Sep 5;22(1):144. doi: 10.1186/s12944-023-01884-2.

生活方式与脂蛋白(a)水平:特定的咨询有意义吗?

Lifestyle and Lipoprotein(a) Levels: Does a Specific Counseling Make Sense?

作者信息

Fogacci Federica, Di Micoli Valentina, Sabouret Pierre, Giovannini Marina, Cicero Arrigo F G

机构信息

Hypertension and Cardiovascular Risk Research Center, Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, 40100 Bologna, Italy.

INSERM UMRS_1166, Cardiology Institute, Pitié Salpêtrière Hospital (AP-HP), ACTION Study Group, Sorbonne University, 75013 Paris, France.

出版信息

J Clin Med. 2024 Jan 28;13(3):751. doi: 10.3390/jcm13030751.

DOI:10.3390/jcm13030751
PMID:38337445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10856708/
Abstract

Lipoprotein(Lp)(a) is a variant of low-density lipoprotein (LDL), bound to apolipoprotein B100, whose levels are associated with a significant increase in the risk of atherosclerosis-related cardiovascular events, but also to aortic stenosis and atrial fibrillation. Since plasma levels of Lp(a) are commonly considered resistant to lifestyle changes, we critically reviewed the available evidence on the effect of weight loss, dietary supplements, and physical activity on this risk factor. In our review, we observed that relevant body weight loss, a relatively high intake of saturated fatty acids, the consumption of red wine, and intense physical exercise seems to be associated with significantly lower plasma Lp(a) levels. On the contrary, foods rich in trans-unsaturated fatty acids are associated with increased Lp(a) levels. With regard to dietary supplements, coenzyme Q10, L-Carnitine, and flaxseed exert a mild but significant lowering effect on plasma Lp(a).

摘要

脂蛋白(a)[Lp(a)]是一种与载脂蛋白B100结合的低密度脂蛋白(LDL)变体,其水平与动脉粥样硬化相关心血管事件风险的显著增加有关,也与主动脉瓣狭窄和心房颤动有关。由于血浆Lp(a)水平通常被认为对生活方式改变具有抗性,我们严格审查了关于体重减轻、膳食补充剂和体育活动对这一危险因素影响的现有证据。在我们的综述中,我们观察到,相关的体重减轻、相对较高的饱和脂肪酸摄入量、饮用红酒以及高强度体育锻炼似乎与显著降低的血浆Lp(a)水平相关。相反,富含反式不饱和脂肪酸的食物与Lp(a)水平升高有关。关于膳食补充剂,辅酶Q10、左旋肉碱和亚麻籽对血浆Lp(a)有轻微但显著的降低作用。